What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Cytokine
His primary scientific interests are in Immunology, Cell biology, T cell, Cytokine and Signal transduction.
His research in Cell biology intersects with topics in Interferon, CD3 and Genetic enhancement, Gene.
His biological study spans a wide range of topics, including Peptide sequence and Picornavirus.
His study in T cell is interdisciplinary in nature, drawing from both Molecular biology and Cytotoxic T cell.
His Cytotoxic T cell research integrates issues from CD8 and MHC class II.
In his study, Natural killer cell, Haematopoiesis and Interferon gamma is strongly linked to Interleukin 12, which falls under the umbrella field of Cytokine.
His most cited work include:
- How regulatory T cells work. (2075 citations)
- The inhibitory cytokine IL-35 contributes to regulatory T-cell function (1419 citations)
- Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection (1358 citations)
What are the main themes of his work throughout his whole career to date?
Dario A. A. Vignali focuses on Immunology, T cell, Cell biology, Immune system and T-cell receptor.
His study in Immunology focuses on Autoimmunity, Immune tolerance, FOXP3, Antigen and Cytokine.
His research integrates issues of Molecular biology and CD8 in his study of T cell.
His research in Cell biology focuses on subjects like Regulatory T cell, which are connected to Cancer vaccine.
His Immune system research includes elements of Cancer, Cancer research and Antibody.
His studies deal with areas such as Epitope, CD3 and Major histocompatibility complex as well as T-cell receptor.
He most often published in these fields:
- Immunology (46.38%)
- T cell (41.30%)
- Cell biology (36.23%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (17.03%)
- Immune system (26.09%)
- CD8 (19.57%)
In recent papers he was focusing on the following fields of study:
Dario A. A. Vignali mainly investigates Cancer research, Immune system, CD8, Immunotherapy and T cell.
His work carried out in the field of Cancer research brings together such families of science as Tumor microenvironment, Head and neck squamous-cell carcinoma, Cancer immunotherapy and Cytotoxic T cell, LAG3.
His Immune system study integrates concerns from other disciplines, such as Cancer, Antibody, Monoclonal antibody and Cytokine.
His Antibody research is classified as research in Immunology.
The study incorporates disciplines such as Acquired immune system, Immune tolerance and Cell biology in addition to T cell.
His research on Cell biology focuses in particular on Effector.
Between 2018 and 2021, his most popular works were:
- Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3 (179 citations)
- Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups. (85 citations)
- Adaptive plasticity of IL-10 + and IL-35 + T reg cells cooperatively promotes tumor T cell exhaustion (75 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cytokine
Cancer research, CD8, Immunotherapy, Immune system and Cancer immunotherapy are his primary areas of study.
As a member of one scientific family, Dario A. A. Vignali mostly works in the field of Cancer research, focusing on Cancer and, on occasion, Receptor and Antigen.
His Immunotherapy research includes themes of Malignant transformation, Head and neck squamous-cell carcinoma, Head and neck cancer, Cytokine and Immunity.
His Cancer immunotherapy research incorporates elements of Tumor microenvironment, T cell, LAG3 and Immune checkpoint.
His T cell study combines topics from a wide range of disciplines, such as Immune tolerance and Cell biology.
He interconnects Peripheral tolerance and FOXP3 in the investigation of issues within Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
